Schedule 13G ownership disclosure

Emergent BioSolutions Inc

Security class unavailable · CUSIP: 29089Q105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,352,952
Percent of class
10.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-031867
Form type
SC 13G/A
Filer
Emergent BioSolutions Inc.
CIK
CIK 1367644
Filed
Mar 09, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub